Top entities: Innate Pharma, Stéphanie Cornen, United States — United States Securities and Exchange Commission, Sanofi, Nasdaq-100.

What category does this event fall under?

Business — classified as Annual Meeting.

What is the sentiment of coverage?

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This event is archived — the story has concluded and this page is a final snapshot.

Business Annual Meeting

Innate Pharma 2026 AGM Results

Q: When did this event occur?

First reported May 22, 2026; last updated May 22, 2026.

Q: What is the market impact?

General. The announcement of the Annual General Meeting results by Innate Pharma is a routine corporate governance event.

Analysis based on 6 articles · First reported May 22, 2026 · Last updated May 22, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The announcement of the Annual General Meeting results by Innate Pharma is a routine corporate governance event. It provides transparency to shareholders and the market regarding the company's operations and compliance, but typically has a neutral impact on the stock price of Innate Pharma unless unexpected resolutions were voted upon.

Biotechnology Pharmaceuticals

Event Summary

Innate Pharma SA announced the voting results of its Annual General Meeting (AGM) held on May 21, 2026, in Marseille. All resolutions presented to the shareholders were voted upon. The company reported a quorum of 37.136% with 94 votes cast out of 34,872,293 shares. The results and related documents will be made available on Innate Pharma's website. Innate Pharma is a clinical-stage biotechnology company focused on developing immunotherapies for cancer patients, with collaborations including Sanofi and AstraZeneca. The company is listed on Euronext Paris and Nasdaq.

Entities Involved

stock

Innate Pharma

Innate Pharma announced the voting results of its Annual General Meeting, which is a routine corporate governance event. The event confirms the company's adherence to regulatory requirements and shareholder engagement.

Importance 100.0 Sentiment 0.0

per

Stéphanie Cornen

Stéphanie Cornen is listed as a contact for Investors & Media Relations for Innate Pharma.

Importance 5.0 Sentiment 0.0

govactor

United States — United States Securities and Exchange Commission

Importance 0.0 Sentiment 0.0

stock

Sanofi

Importance 0.0 Sentiment 0.0

index